Vaccination of myeloma patients with monoclonal immunoglobulin loaded dendritic cells:: preclinical and first clinical results of a phase I/II clinical trial

被引：0
|
作者：
Ocadlikova, D.
Zahradova, L.
Kovarova, L.
Smejkalova, J.
Pour, L.
Vidlakova, P.
Kyjovska, D.
Stejskalova, A.
Novotna, H.
Penka, M.
Michalek, J.
Hajek, R.
机构：
[1] Masaryk Univ, Cell Immunotherapy Ctr, Brno, Czech Republic
[2] Univ Hosp, Dept Hematooncol, Brno, Czech Republic
[3] Univ Hosp, Dept Pediat 1, Brno, Czech Republic
[4] Univ Hosp, Dept Clin Hematol, Brno, Czech Republic
[5] Univ Hosp, Dept Clin Biochem, Brno, Czech Republic
来源：
BLOOD REVIEWS | 2007年 / 21卷
关键词：
D O I：
10.1016/S0268-960X(07)70213-8
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：S129 / S129
页数：1
相关论文
共 50 条
  • [21] Vaccination of recurrent glioma patients with tumour lysate-pulsed dendritic cells elicits immune responses: results of a clinical phase I/II trial
    Yamanaka, R
    Abe, T
    Yajima, N
    Tsuchiya, N
    Tsuchiya, N
    Homma, J
    Kobayashi, T
    Narita, M
    Takahashi, M
    Tanaka, R
    BRITISH JOURNAL OF CANCER, 2003, 89 (07) : 1172 - 1179
  • [22] Vaccination of recurrent glioma patients with tumour lysate-pulsed dendritic cells elicits immune responses: results of a clinical phase I/II trial
    R Yamanaka
    T Abe
    N Yajima
    N Tsuchiya
    J Homma
    T Kobayashi
    M Narita
    M Takahashi
    R Tanaka
    British Journal of Cancer, 2003, 89 : 1172 - 1179
  • [23] Vaccination of recurrent glioma patients with tumour lysate-pulsed dendritic cells elicits immune responses: Results of a clinical phase I/II trial
    Yamanaka, R
    Homma, J
    Yajima, N
    Tsuchiya, N
    Tanaka, R
    MOLECULAR THERAPY, 2004, 9 : S98 - S98
  • [24] DENDRITIC CELL VACCINATION IN POSTREMISSION THERAPY OF AML: RESULTS OF A CLINICAL PHASE I TRIAL AND OF PRECLINICAL STUDIES TESTING COMBINATORIAL APPROACHES
    Schnorfeil, F.
    Lichtenegger, F.
    Rothe, M.
    Schlueter, M.
    Neitz, J.
    Brueggemann, M.
    Moosmann, A.
    Wagner, B.
    Henschler, R.
    Koehnke, T.
    Buecklein, V.
    Altmann, T.
    Geiger, C.
    Hiddemann, W.
    Bigalke, I.
    Kvalheim, G.
    Schendel, D.
    Subklewe, M.
    HAEMATOLOGICA, 2015, 100 : 287 - 287
  • [25] TLR7/8-matured dendritic cells for therapeutic vaccination in AML: Results of a clinical Phase I/II trial
    Deiser, Katrin
    Lichtenegger, Felix S.
    Schnorfeil, Frauke M.
    Kohnke, Thomas
    Altmann, Torben
    Bucklein, Veit
    Augsberger, Christian
    Moosmann, Andreas
    Bruggemann, Monika
    Heemskerk, Mirjam H. M.
    Wagner, Beate
    Hiddemann, Wolfgang
    Bigalke, Iris
    Kvalheim, Gunnar
    Subklewe, Marion
    CANCER IMMUNOLOGY RESEARCH, 2016, 4 (11)
  • [26] Results of a Phase II clinical trial with Id-protein-loaded dendritic cell vaccine in multiple myeloma: encouraging or discouraging?
    Garcia-Marquez, Maria A.
    Wennhold, Kerstin
    Draube, Andreas
    von Bergwelt-Baildon, Michael
    IMMUNOTHERAPY, 2012, 4 (10) : 991 - 994
  • [27] Phase I/II clinical trial of immunotherapy by intratumoral administration of dendritic cells for patients with melanoma
    Saito, Masataka
    Fujita, Tomonobu
    Tanikawa, Akiko
    Ishida, Akaru
    Sakurai, Toshiharu
    Handa, Makoto
    Amagai, Masayuki
    Kawakami, Yutaka
    PIGMENT CELL & MELANOMA RESEARCH, 2008, 21 (02) : 328 - 328
  • [28] Next-generation dendritic cell vaccination in postremission therapy of AML: Results of a clinical phase I/II trial
    Deiser, K.
    Lichtenegger, F.
    Schnorfeil, F.
    Koehnke, T.
    Altmann, T.
    Buecklein, V.
    Moosmann, A.
    Brueggemann, M.
    Heemskerk, M. H. M.
    Wagner, B.
    Hiddemann, W.
    Bigalke, I.
    Kvalheim, G.
    Subklewe, M.
    EUROPEAN JOURNAL OF CANCER, 2016, 55 : S22 - S23
  • [29] PHASE I/II OF CLINICAL STUDY OF PROSTATE CANCER IMMUNOTHERAPY USING DENDRITIC CELL VACCINATION STRATEGY - FIRST RESULTS
    Minarik, I
    Horvath, R.
    Podrazil, M.
    Hromadkova, H.
    Dusek, P.
    Jarolim, L.
    Babjuk, M.
    Bartunkova, J.
    EUROPEAN UROLOGY SUPPLEMENTS, 2010, 9 (06) : 629 - 629
  • [30] Dendritic Cells Immunotherapy: A Phase II Clinical Trial
    Zahradova, L.
    Stejskalova, A.
    Novotna, H.
    Jelinkova, I.
    Penka, M.
    Hajek, R.
    Ocadlikova, D.
    Kovarova, L.
    Smejkalova, J.
    Pour, L.
    Vidlakova, P.
    Kyjovska, D.
    Michalek, J.
    CLINICAL LYMPHOMA & MYELOMA, 2009, 9 : S80 - S81
12345